// company-profile

Verrica Pharmaceuticals Inc.

VRCA
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings74Insiders19
// api This Verrica Pharmaceuticals Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares. Buying was led by Eichenfield Lawrence.

// 90-day insight

Over the last 90 days, Verrica Pharmaceuticals Inc. insiders bought $0 across 7 transactions with no open-market sales.

  • Most active insider: Eichenfield Lawrence with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Verrica Pharmaceuticals Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$24.9M
QoQ change
-42.0%
Reporting period
2026-03-31
#1
Caligan Partners LP
CIK 1727492
$4.9M
924K shares
#2
Affinity Asset Advisors, LLC
CIK 1773195
$3.7M
707K shares
#3
CANNELL CAPITAL LLC
CIK 1058854
$3.6M
685K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 5, 2026Eichenfield LawrenceVRCA
Award
16,000$0.00$0K
Jun 5, 2026Zawitz DavidVRCA
Award
171,340$0.00$0K
Jun 5, 2026Rieger JaysonVRCA
Award
512,269$0.00$0K
Jun 5, 2026Nguyen DiemVRCA
Award
16,000$0.00$0K
Jun 5, 2026Rosenberg Noah L.VRCA
Award
233,840$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.